Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices 55805 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Initial Review 

Group, Biomedical Research and Research 

Training Review Subcommittee A. 

Date: November 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Carole H. Latker, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18, Bethesda, 

MD 20892. 301–594–2848. 

latkerc@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: September 8, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–22842 Filed 9–13–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Interagency Breast Cancer and 

Environmental Research Coordinating 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Interagency Breast 

Cancer and Environmental Research 

Coordinating Committee. 

Date: September 30–October 1, 2010. 

Time: 8:30 a.m. to 3:30 p.m. 

Agenda: The purpose of the meeting is to 

initiate the work of the Committee, which is 

to share and coordinate information on 

existing research activities, and to make 

recommendations to the National Institutes 

of Health and other Federal agencies 

regarding how to improve existing research 

programs related to breast cancer and the 

environment. 

Place: JW Marriott, 1313 Pennsylvania 

Avenue, NW., Washington, DC 20004. 

Contact Person: Gwen W. Collman, PhD, 

Acting Director, Division of Extramural 

Research and Training, National Institute of 

Environmental Health Sciences, 615 Davis 

Dr., KEY615/3112, Research Triangle Park, 

NC 27709. (919) 541–4980. 

collman@niehs.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

should submit their remarks in writing at 

least 10 days in advance of the meeting. 

Comments in document format (i.e. WORD, 

Rich Text, PDF) may be uploaded via the 

following Web site: https://www.cmpinc.net/ 

IBCERCC. Alternatively, comments may be 

submitted via e-mail to the Contact Person 

listed on this notice. You do not need to 

attend the meeting in order to submit 

comments. 

Interested individuals and representatives 

of organizations may submit a letter of intent, 

a brief description of the organization 

represented, and a short description of the 

oral comments you wish to present. Only one 

representative per organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. Oral 

comments will begin at approximately 4:15 

p.m. on Thursday, September 30, 2010. 

Although time will not be allotted for 

comments on Friday, October 1, 2010, 

members of the public are welcome to attend 

the entire meeting. 

Anyone who wishes to attend the meeting 

and/or submit comments to the committee is 

asked to RSVP via the following Web site: 

https://www.cmpinc.net/IBCERCC. All 

comments are delivered to the Contact 

Person listed on this notice. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation— Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: September 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–22830 Filed 9–13–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0001] 

Arthritis Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Arthritis 

Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on November 16, 2010, from 8 a.m. 

to 5 p.m. 

Location: The Marriott Inn and 

Conference Center, University of 

Maryland University College, 3501 

University Blvd East, Adelphi, MD. The 

conference center telephone number is 

301–985–7300. 

Contact Person: Anuja Patel, Center 

for Drug Evaluation and Research, Food 

and Drug Administration, 10903 New 

Hampshire Ave., WO31–2417, Silver 

Spring, MD 20993–0002, 301–796–9001, 

FAX: 301–847–8533, email: 

anuja.patel@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512532. Please call the Information 

Line for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 


jlentini on DSKJ8SOYB1PROD with NOTICES